For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
Blog
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time…
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
Search Posts
Blog
The Growing Groupthink Problem in Science and Policy
Government Dietary Guidelines issued jointly by the Departments of Agriculture (USDA) and Health and Human Services (HHS) every five years are meant to provide…
National Review
Why Is Israel Doing Better Than Everyone Else in COVID Vaccinations?
Eleven years ago, Dan Senor and Saul Singer dubbed Israel the “Start Up Nation” for its disproportionately large number of technology start-ups and NASDAQ stock…
Blog
Employers Will Pay Workers to Get a Covid-19 Vaccine
The federal government, through Operation Warp speed, helped develop and bring to market vaccines against the new disease COVID-19 in less than a year,…
City Journal
AUDIO: Joel Zinberg Joins the 10 Blocks Podcast to Discuss COVID Vaccine Rollout
Senior Fellow Joel Zinberg joins Brian Anderson at City Journal to discuss the slow rollout of coronavirus vaccines, why states…
City Journal
End Covid Now
More than 22 million doses of Covid-19 vaccine have been distributed in the United States so far, yet only …
National Review
Why Are We Vaccinating People Who Have Recovered from COVID-19?
Now that Pfizer and Moderna have received emergency-use authorizations for their COVID-19 vaccines, the tough work of deciding how to allocate the limited supply of…